Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival.

作者信息

Kumar A M, Fa K, Vankawala R, Vora M, Kode R K, Pankewycz O G, Lattavi M R, Fyfe B, Damask A M, Ferry E, Stabler S, Tomeny M B, Phillips K, Lingaraju R, Kumar M S

机构信息

Department of Transplantation, MCP Hahnemann University, Philadelphia, Pennsylvania 19102, USA.

出版信息

Transplant Proc. 2001 Nov-Dec;33(7-8):3195-6. doi: 10.1016/s0041-1345(01)02359-4.

DOI:10.1016/s0041-1345(01)02359-4

PMID:11750370

Abstract

摘要

相似文献

Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival.

Transplant Proc. 2001 Nov-Dec;33(7-8):3195-6. doi: 10.1016/s0041-1345(01)02359-4.

Mycophenolate mofetil improves long-term graft survival following renal transplantation in patients experiencing delayed graft function. International Mycophenolate Mofetil Renal Study Groups.

Transplant Proc. 1999 Feb-Mar;31(1-2):322-3. doi: 10.1016/s0041-1345(98)01645-5.

The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation.

Clin Transplant. 2003 Jun;17(3):200-5. doi: 10.1034/j.1399-0012.2003.00026.x.

Improved primary transplant success rates using a triple regimen of cyclosporine microemulsion, mycophenolate mofetil and prednisone.

Transplant Proc. 2001 Aug;33(5):2776-7. doi: 10.1016/s0041-1345(01)02187-x.

Kidney transplantation without calcineurin inhibitors using sirolimus.

Transplant Proc. 2003 May;35(3 Suppl):125S-127S. doi: 10.1016/s0041-1345(03)00226-4.

Mycophenolate mofetil for prevention of acute rejection.

Lancet. 1995 Jul 22;346(8969):253.

Rates of acute rejection by recipient race and type of calcineurin inhibitor with mycophenolate mofetil.

Transplant Proc. 2002 Dec;34(8):3119-21. doi: 10.1016/s0041-1345(02)03662-x.

Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid.

Transplant Proc. 2005 Mar;37(2):791-4. doi: 10.1016/j.transproceed.2004.12.185.

Mycophenolate mofetil in pediatric renal transplantation.

Pediatr Transplant. 1999 Feb;3(1):33-7. doi: 10.1034/j.1399-3046.1999.00003.x.

Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group.

Transplant Proc. 1997 Feb-Mar;29(1-2):348-9. doi: 10.1016/s0041-1345(96)00302-8.

引用本文的文献

African American kidney transplantation survival: the ability of immunosuppression to balance the inherent pre- and post-transplant risk factors.

Drugs. 2009 Oct 22;69(15):2045-62. doi: 10.2165/11318570-000000000-00000.

The role of basiliximab in the evolving renal transplantation immunosuppression protocol.

Biologics. 2008 Jun;2(2):175-88. doi: 10.2147/btt.s1437.

Basiliximab: a review of its use as induction therapy in renal transplantation.

Drugs. 2003;63(24):2803-35. doi: 10.2165/00003495-200363240-00009.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验